Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk.
Raine-Bennett T, Chandra M, Armstrong MA, Alexeeff S, Lo JC.
Obstet Gynecol. 2019 Sep;134(3):581-589. doi: 10.1097/AOG.0000000000003414.
An Unusual Case of Spontaneous Fracture and Vesical Transmigration of Intrauterine Contraceptive Device.
Shah K, Bhat R, Shivaramaiya M, Hegde P.
J Obstet Gynaecol India. 2023 Dec;73(6):544-546. doi: 10.1007/s13224-023-01763-x. Epub 2023 Jun 7.
Intrauterine contraceptive device rupture. Follow-up of a retrospective cohort and clinical protocol. RUDIUS study.
Cánovas E, Beric D, Jara R, Cazorla E.
Heliyon. 2022 Jan 12;8(1):e08751. doi: 10.1016/j.heliyon.2022.e08751. eCollection 2022 Jan.
Evidence-Based Contraception: Common Questions and Answers.
Paradise SL, Landis CA, Klein DA.
Am Fam Physician. 2022 Sep;106(3):251-259.
IUD fracture mechanism.
Goldstuck ND.
Contraception. 2014 Apr;89(4):328. doi: 10.1016/j.contraception.2013.12.004. Epub 2013 Dec 19.
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women.
Vestergaard P, Rejnmark L, Mosekilde L.
Contraception. 2008 Dec;78(6):459-64. doi: 10.1016/j.contraception.2008.07.014. Epub 2008 Sep 10.
Controversies in contraception for women with epilepsy.
Thomas SV.
Ann Indian Acad Neurol. 2015 Jul-Sep;18(3):278-83. doi: 10.4103/0972-2327.162261.
Role of uterine forces in intrauterine device embedment, perforation, and expulsion.
Goldstuck ND, Wildemeersch D.
Int J Womens Health. 2014 Aug 7;6:735-44. doi: 10.2147/IJWH.S63167. eCollection 2014.
Hormonal contraception and medical readiness for female service members.
Ricker EA, Koltun KJ, de la Motte SJ.
Am J Obstet Gynecol. 2024 Oct;231(4):386-394. doi: 10.1016/j.ajog.2024.05.044. Epub 2024 May 27.
Bone health and hormonal contraception.
Rocca ML, Palumbo AR, Bitonti G, Brisinda C, DI Carlo C.
Minerva Obstet Gynecol. 2021 Dec;73(6):678-696. doi: 10.23736/S2724-606X.20.04688-2.
